Covishield, vaccine candidate by SII, approved for emergency use by a Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI)
Covishield, vaccine candidate by Pune-based Serum Institute of India, approved by a Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI)
It is the variant of the Oxford-AstraZeneca vaccine that is being manufactured under licence in India by SII
Comments
Post a Comment